GlassScriptPhysician profile
You Wei Lin
NPI 1164084976
$616.54
in general payments reported to CMS, 2019-2025
17 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.86 · 2022: $13.09 · 2023: $156 · 2024: $180 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $114.92 | 2023-2025 | |
| Abbvie INC. | $108.65 | 2023-2025 | |
| Acell, INC. | $56.86 | 2019 | |
| Viatris Specialty LLC | $38.21 | 2025 | Yupelri |
| Lilly USA, LLC | $33.18 | 2025 | Zepbound, Mounjaro |
| Mylan Specialty L.P. | $32.64 | 2023-2024 | Yupelri |
| Sanofi Pasteur INC. | $31.86 | 2023-2025 | |
| Shield Therapeutics INC | $30.03 | 2023-2024 | Accrufer |
| Astellas Pharma US INC | $24.61 | 2024 | Veozah |
| Axsome Therapeutics, INC. | $23.20 | 2024 | Auvelity |
| Exact Sciences Corporation | $21.94 | 2023 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $20.73 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $19.43 | 2024 | Austedo Xr |
| Dynavax Technologies Corporation | $18.75 | 2025 | Heplisav-B |
| Novo Nordisk INC | $15.72 | 2024 | Wegovy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $13.09 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.72 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw You Wei Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.